View Archive »
About The Cover
The cover for issue 43 of Oncotarget features Figure 2A, "Silencing GLI1 influences GBM cell response to TMZ and reduces multidrug efflux activity," by Melamed, et al.
|
|
Table of Contents
Research Papers
|
| Optimization of cervical lymph node clinical target volume delineation in nasopharyngeal carcinoma: a single center experience and recommendation |
|
https://doi.org/10.18632/oncotarget.23723
|
| 26980-26989 |
|
| Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer GFTC |
|
https://doi.org/10.18632/oncotarget.25454
|
| 26990-26999 |
|
| Investigating the role of Hedgehog/GLI1 signaling in glioblastoma cell response to temozolomide |
|
https://doi.org/10.18632/oncotarget.25467
|
| 27000-27015 |
|
| KCTD12 is negatively regulated by Kit in gastrointestinal stromal tumors |
|
https://doi.org/10.18632/oncotarget.25469
|
| 27016-27026 |
|
| Serum levels of soluble urokinase plasminogen activator receptor suPAR predict outcome after resection of colorectal liver metastases |
|
https://doi.org/10.18632/oncotarget.25471
|
| 27027-27038 |
|
| Hypoxia leads to decreased autophosphorylation of the MET receptor but promotes its resistance to tyrosine kinase inhibitors |
|
https://doi.org/10.18632/oncotarget.25472
|
| 27039-27058 |
|
| LRP/LR specific antibody IgG1iS18 impedes neurodegeneration in Alzheimer's disease mice |
|
https://doi.org/10.18632/oncotarget.25473
|
| 27059-27073 |
|
| Monitoring EGFRT790M mutation in serum/plasma for prediction of response to thirdgeneration EGFR inhibitors in patients with lung cancer |
|
https://doi.org/10.18632/oncotarget.25478
|
| 27074-27086 |
|
| Frequent epigenetic alterations in polycomb repressive complex 2 in osteosarcoma cell lines |
|
https://doi.org/10.18632/oncotarget.25484
|
| 27087-27091 |
|
| Favorable prognostic role of tropomodulins in neuroblastoma |
|
https://doi.org/10.18632/oncotarget.25491
|
| 27092-27103 |
|
| The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer |
|
https://doi.org/10.18632/oncotarget.25497
|
| 27104-27116 |
|
| Reduced vasorin enhances angiotensin II signaling within the aging arterial wall |
|
https://doi.org/10.18632/oncotarget.25499
|
| 27117-27132 |
|
| Global metabolite profiling analysis of lipotoxicity in HER2/neupositive breast cancer cells |
|
https://doi.org/10.18632/oncotarget.25500
|
| 27133-27150 |
|
| Acute telomere deprotection prevents ongoing BFB cycles and rampant instability in p16INK4adeficient epithelial cells |
|
https://doi.org/10.18632/oncotarget.25502
|
| 27151-27170 |
|
| Prognostic values of the mRNA expression of natural killer receptor ligands and their association with clinicopathological features in breast cancer patients |
|
https://doi.org/10.18632/oncotarget.25506
|
| 27171-27196 |
|
| WNK1 kinase and its partners Akt SGK1 and NBCfamily Na+/HCO3– cotransporters are potential therapeutic targets for glioblastoma stemlike cells linked to Bisacodyl signaling |
|
https://doi.org/10.18632/oncotarget.25509
|
| 27197-27219 |
|
| Effect of combined inhibition of p110 alpha PI3K isoform and STAT3 pathway in ovarian cancer platinumbased resistance |
|
https://doi.org/10.18632/oncotarget.25513
|
| 27220-27232 |
|
| Construction and characterization of a new TRAIL soluble form active at picomolar concentrations |
|
https://doi.org/10.18632/oncotarget.25519
|
| 27233-27241 |
|
| Overcoming drugtolerant cancer cell subpopulations showing AXL activation and epithelial–mesenchymal transition is critical in conquering ALKpositive lung cancer |
|
https://doi.org/10.18632/oncotarget.25531
|
| 27242-27255 |
|
| Extensive screening of microRNA populations identifies hsamiR375 and hsamiR133a3p as selective markers for human rectal and colon cancer |
|
https://doi.org/10.18632/oncotarget.25535
|
| 27256-27267 |
|
| Discovery and optimization of cardenolides inhibiting HSF1 activation in human colon HCT116 cancer cells |
|
https://doi.org/10.18632/oncotarget.25545
|
| 27268-27279 |
|
| Butyrate decreases its own oxidation in colorectal cancer cells through inhibition of histone deacetylases |
|
https://doi.org/10.18632/oncotarget.25546
|
| 27280-27292 |
|
| Role of WNT5A receptors FZD5 and RYK in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.25551
|
| 27293-27304 |
|
| Increased circulating CD4+FOXP3+ T cells associate with early relapse following autologous hematopoietic stem cell transplantation in multiple myeloma patients |
|
https://doi.org/10.18632/oncotarget.25553
|
| 27305-27317 |
Corrections
|
| Correction: Sirt3mediated mitophagy protects tumor cells against apoptosis under hypoxia |
|
https://doi.org/10.18632/oncotarget.25620
|
| 27318-27318 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
